[ad_1]
Levi Strauss & Co. stuck with its full-year sales outlook, helped by demand for new denim and women’s clothing, but the jeans maker’s quarterly sales just missed expectations, and it said it expected higher costs from marketing and a change in how it plans to store and ship clothing.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...